Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure
- 31 July 1995
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (1) , 248-255
- https://doi.org/10.1016/0272-6386(95)90180-9
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patientsKidney International, 1995
- Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patientsKidney International, 1995
- Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combinationKidney International, 1994
- Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes.Journal of Clinical Investigation, 1994
- Evaluation of the Effect of Intravenous L-Carnitine Therapy on Function, Structure and Fatty Acid Metabolism of Skeletal Muscle in Patients Receiving Chronic HemodialysisNephron, 1991
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Protein synthesis and degradation in skeletal muscle of chronically uremic ratsKidney International, 1986
- Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody.Journal of Clinical Investigation, 1984
- In vitro inhibition of protein synthesis by dialysates of plasma from uraemic patientsEuropean Journal of Clinical Investigation, 1981
- The Regulation of Skeletal Muscle Alanine and Glutamine Formation and Release in Experimental Chronic Uremia in the RatJournal of Clinical Investigation, 1978